Biotech Law 
United States: Non-Legal Perspectives On Isolated DNA: The Watson And Holman Amicus Briefs In The Myriad Remand – Mondaq
biotechnology companies that produce biotech drugs … I can say that the Watson and Holman breifs provided a refreshing break from the natural phenomenon vs. law of nature, Prometheus vs. Chakrabarty debate. For that reason alone these briefs may …
Report: Oregon bioscience industry rising – The Business Journal
The BIO/Batelle State Bioscience Industry Development 2012 Report said the state has added nearly 12 percent more biotech related businesses … Andy Giegerich covers government, law, health care and sports business.
Davis biotech firm has deal to help Asian tomato market – Worldnews.com
In addition, we may disclose any information, including personally identifiable information, we deem necessary, in our sole discretion, to comply with any applicable law, regulation, legal proceeding or governmental request. We do not want you …
Taxman summons Shanta Biotech top brass on Sanofi deal; Sanofi may challenge retro tax laws – Economic Times
In one of the biggest deals in the Indian biotech sector, Sanofi Aventis had in 2009 acquired … company ShanH was subject to a taxation in France, under the French law, the company said in a statement.”The parties have therefore … Continue reading
Guatemalans Used in Experiments Deserve Compensation – New York Times
is faculty co-director of its Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics. Holly Fernandez Lynch, a lecturer at Harvard Law School and the Petrie-Flom Center’s executive director, was on the staff of the Presidential …
Nigeria: ‘Nigeria Needs Biotechnology to Avoid Starvation’ – AllAfrica.com
He concluded that the only way to open that door for our people is through biotechnology. The Director General of NABDA, Professor Bamidele Solomon said “we need aBiosafety law in place, because when we have a law, we will be … Continue reading
Stakeholders query Jonathan over biotech bill – Businessday Online
President Goodluck Jonathan is under knocks from stakeholders including members of the National Assembly over his inability to sign into law till date the agricultural biotechnology bill which was passed by the 6th National Assembly since June 2011.
Next generation stent coatings: convergence of biotechnology and nanotechnology
Aaron Tan, Mohammad S. Alavijeh, Alexander M. Seifalian.
Mass spectrometry imaging is moving toward drug protein co-localization
Rima Ait-Belkacem, Lyna Sellami, Claude Villard, Edwin DePauw, David Calligaris, Daniel Lafitte. Mass spectrometry (MS)-based technology provides label-free localization of molecules in tissue samples. Drugs, proteins, lipids and metabolites can easily be monitored in their environment. Resol….
Nigeria: Stakeholders Challenge Jonathan Over Agricultural Biotechnology Law – AllAfrica.com
Ibadan — Stakeholders including members of the National Assembly have berated President Goodluck Jonathan over his inability to assent into law till date the agricultural biotechnology bill which was passed by the 6th National Assembly since June 2011.
